ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,855, issued on Jan. 13, was assigned to TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (Ramat Gan, Israel).
"Methods and kits for identifying thrombus origin and optimizing post-ischemic event treatment" was invented by David Orion (Kiryat Ono, Israel), Zeev Itsekson-Hayosh (Tel Aviv-Yaffo, Israel), Efrat Shavit-Stein (Pardes Hanna-Karkur, Israel) and Joab Chapman (Kiriat Ono, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are method and kits for identifying thrombus origin based on temporal thrombin activity assay, and use thereof for optimizing post-ischemic event treatment, and further preventing recurrence ...